Project Grant R21AI196130
Award Date 6/19/26
Completion Date 5/31/28
Dollars Obligated $520K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Alamos, NM 87545, USA
Similar Awards
- Federal Project Grant Award Summary The University of New Mexico received a $430,251 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 18, 2025, with a completion date of May 31, 2027. This award supports fine-resolution genetic mapping research utilizing advanced intercross lines of Biomphalaria glabrata, a primary snail vector for Schistosoma mansoni. The project employs double...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a $420,228 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 5, 2026, with a completion date of May 31, 2028. This secondary data analysis study will examine the relationship between dust exposure and coccidioidomycosis incidence in Arizona using a novel database of spatiotemporally refined dust...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $438,038 to the Regents of the University of California, Berkeley, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period running from July 15, 2025 through June 30, 2027. This Project Grant funds a molecular research initiative investigating the regulation of infectious spore formation in Coccidioides posadasii, the fungal pathogen...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant of $677,822 under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of June 2, 2026 and completion date of May 31, 2031. This research initiative aims to advance methodologies for estimating population immunity to Coccidioides fungus and identifying exposures associated with prior infection in the U.S....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases awarded the University of New Mexico Health Sciences Center a Project Grant totaling $228,750 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 17, 2026, with completion scheduled for May 31, 2028. This research initiative focuses on investigating how trichloroethylene (TCE), an industrial solvent and environmental contaminant, impairs immune tolerance mechanisms and contributes...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Arizona a $3.1 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 5, 2026, through May 31, 2030. This research initiative focuses on the identification and characterization of novel antifungal compounds targeting dihydroorotate dehydrogenase (DHODH) in Cryptococcus neoformans and Cryptococcus gattii. The project...
- Federal Grant Award Summary Health Research, Inc.'s Wadsworth Center received a $2,055,164 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 18, 2025, with completion targeted for June 30, 2030. The project focuses on developing the therapeutic potential of D29-LYSB, a mycobacteriophage lysin enzyme, as a broad-spectrum treatment for Mycobacterium abscessus (MAB)...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the J. Craig Venter Institute, Inc. a Project Grant of $556,375 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, with a completion date of June 30, 2027. The research focuses on identifying the molecular determinants governing thermoadaptation and parasitic growth in Histoplasma capsulatum, a dimorphic fungal pathogen responsible for pulmonary and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $923,708 Project Grant to the La Jolla Institute for Immunology for the period April 1, 2026 through March 31, 2031 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports the development of a therapeutic monoclonal antibody (MAb) cocktail targeting New World arenaviruses, including Machupo and Junin viruses, which cause hemorrhagic fever. The...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $133,800 to Fundacion Instituto De Investigaciones Biotecnologicas under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 11, 2025, for a project period extending through July 31, 2030. This Project Grant funds biomedical research investigating protein trafficking mechanisms in Trypanosoma cruzi, the parasitic agent responsible for Chagas disease, which...